NCT00167791View on ClinicalTrials.gov

Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
End Stage Renal Disease
Interventions
DRUG

rituximab

Rituximab 375mg/m2 IV weekly times 4 weeks

Trial Locations (1)

53792

University of Wisconsin, Madison

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT00167791 - Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant | Biotech Hunter | Biotech Hunter